HGH Frag 176–191 – Growth Hormone Fragment for Peptide Pathway Research
HGH Frag 176–191 is a synthetic peptide fragment corresponding to the terminal portion of the growth hormone sequence. This fragment is frequently utilized in controlled laboratory settings to study receptor interactions, peptide stability, and metabolic signaling pathways associated with truncated GH analogs.
Lyophilized powder supplied in standard laboratory vials.
Not for injection. Not for clinical or therapeutic use.
📌 Product Specifications
- Form: Lyophilized Powder
- Appearance: White Powder
- Purity: ≥ 98%
- Storage: Store in a cool, dry place. Refrigerate after reconstitution.
🔬 Research Applications
- Peptide–receptor interaction modeling
- Studies involving truncated GH fragments
- Investigations of laboratory-derived metabolic pathways
🧪 Molecular Details
- CAS Number: 87616-84-0
- Molecular Formula: C78H125N23O23S2
- Molecular Weight: 1817.12 g/mol
- Form: Lyophilized Powder
💡 Interested in the Science?
Explore current studies involving truncated GH fragments, peptide signaling pathways, and laboratory models assessing sequence-specific activity.
HGH Frag 176–191 – Growth and Performance Peptide FAQ
This FAQ provides structured technical information regarding the research application, fragment analysis, and analytical documentation of HGH Frag 176–191 for controlled laboratory environments.
1. What type of laboratory material is HGH Frag 176–191?
HGH Frag 176–191 is a research-use peptide fragment supplied exclusively for scientific and analytical applications in non-clinical laboratory environments. It is intended for controlled experimental workflows involving peptide sequence evaluation and signaling pathway observation.
2. What research areas commonly involve HGH Frag 176–191?
Researchers may utilize HGH Frag 176–191 in studies focused on peptide–receptor interaction modeling, growth hormone fragment analysis, metabolic signaling investigations, and laboratory assessments involving synthetic peptide behavior.
3. Why is HGH Frag 176–191 supplied in lyophilized form?
The lyophilized powder format helps support peptide stability, consistent storage conditions, and accurate laboratory measurement procedures. This presentation is commonly preferred for structured research applications requiring reproducible handling and preparation.
4. Is HGH Frag 176–191 suitable for medical or therapeutic applications?
No. HGH Frag 176–191 is strictly restricted to laboratory research use only. It is not intended for injection, pharmaceutical development, clinical treatment, diagnostic procedures, or human and animal consumption.
5. Does HGH Frag 176–191 include analytical quality documentation?
Yes. HGH Frag 176–191 is accompanied by a Certificate of Analysis (COA) outlining key laboratory specifications such as purity standards, molecular identification, and quality control data relevant to scientific research environments.


